Red light therapy

Red light therapy (RLT), also known as photobiomodulation (PBM) or low-level laser therapy (LLLT), is a non-invasive treatment that utilizes specific wavelengths of red (630–700 nm) and near-infrared (800–1100 nm) light to stimulate healing and cellular function. Unlike ultraviolet (UV) light, which can damage the skin, red light is non-ionizing and penetrates deep into tissues—up to 6 millimeters—to interact with cells without producing heat or causing surface damage. It is delivered via various devices, including LED panels, face masks, laser combs, and full-body beds.

The primary mechanism of red light therapy is the activation of cytochrome c oxidase, an enzyme found in the mitochondria that serves as a 'photoacceptor.' When absorbed, the light energy displaces inhibitory nitric oxide, allowing for increased oxygen consumption and the production of adenosine triphosphate (ATP), the cell's energy currency. This 'metabolic nudge' enhances cellular repair, reduces oxidative stress, and stimulates mitochondrial biogenesis (the creation of new mitochondria). Research from 2024 also indicates that RLT can lower blood sugar by increasing cellular glucose demand and improve retinal health by restoring energy production in aged photoreceptors.

For general health, research suggests using a device with wavelengths in the 660 nm (red) and 850 nm (NIR) range. For skin rejuvenation, a 'fluence' of 3–15 J/cm² is recommended, while deeper muscle or joint issues may require 20–60 J/cm². Standard sessions typically last 5–20 minutes, 3–5 times per week. To improve aging eyesight, a 2024 study suggests a brief 3-minute exposure to 670 nm light specifically in the morning. Always wear eye protection (goggles) to prevent retinal strain, and maintain a distance of 6–12 inches from most panels. Beginners should start at 50% of the recommended duration to assess skin sensitivity and avoid the 'biphasic dose response,' where excessive light reverses the therapeutic benefits.